Product Information
CIPROFLOXACIN 0.2% OTIC SOLN is a generic product labeled by Genus Lifesciences Inc., priced at $6.3519 per EA under NDC 64950038114. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Nov 5, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ciprofloxacin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/.25mL
Manufacturer
Genus Lifesciences Inc.NDC
64950038114
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
CIPROFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA217887FDA Approved
11/5/2024
TE Code
AB
On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN 0.2% OTIC SOLN has been published 60 times since Aug 13, 2025, and over the history we have for it it has declined 7.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3519 per EA |
|---|---|
| All-time high | $7.3838 (Nov 12, 2025) |
| All-time low | $6.3519 (Sep 23, 2026) |
| 52-week high | $7.3838 |
| 52-week low | $6.3519 |
| Median price | $6.9329 |
| Average price | $6.9058 |
| Largest weekly change | +6.2% (Sep 17, 2025) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ciprofloxacin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Genus Lifesciences Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciprofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN 0.2% OTIC SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN 0.2% OTIC SOLN, manufactured by Genus Lifesciences Inc., is $6.3519 per EA (NDC 64950038114), effective Sep 30, 2026.
How has the price of CIPROFLOXACIN 0.2% OTIC SOLN changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN 0.2% OTIC SOLN has declined 7.3%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN 0.2% OTIC SOLN?
Since Aug 13, 2025, the NADAC for CIPROFLOXACIN 0.2% OTIC SOLN has ranged from a low of $6.3519 (Sep 23, 2026) to a high of $7.3838 (Nov 12, 2025), with a median of $6.9329 per EA.
Are there cheaper alternatives to CIPROFLOXACIN 0.2% OTIC SOLN?
No other NADAC-published product currently shares the active ingredient and strength of CIPROFLOXACIN 0.2% OTIC SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOXACIN 0.2% OTIC SOLN?
CIPROFLOXACIN 0.2% OTIC SOLN (NDC 64950038114) is labeled by Genus Lifesciences Inc., and CMS classifies it as a generic product.